FDA clears Boston Cell Standards’ IHControls panel in breast cancer

December 1, 2025

Calibration Transforms Accuracy in HER2-Low Breast Cancer Testing

International Study Published in Lancet: eBioMedicine BOSTON – November 19, 2025 — Boston Cell Standards today announced the publication of the CASI-01 study in Lancet: eBioMedicine...

December 20, 2022

National Study Confirms Effectiveness of New Tools for Standardizing Estrogen Receptor Testing

December 20, 2022

Landmark Study by Boston Cell Standards Validates First Reference Standards for Immunohistochemistry Testing